Correlation Between Molecular Partners and XORTX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and XORTX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and XORTX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and XORTX Therapeutics, you can compare the effects of market volatilities on Molecular Partners and XORTX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of XORTX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and XORTX Therapeutics.
Diversification Opportunities for Molecular Partners and XORTX Therapeutics
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Molecular and XORTX is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and XORTX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XORTX Therapeutics and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with XORTX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XORTX Therapeutics has no effect on the direction of Molecular Partners i.e., Molecular Partners and XORTX Therapeutics go up and down completely randomly.
Pair Corralation between Molecular Partners and XORTX Therapeutics
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 0.61 times more return on investment than XORTX Therapeutics. However, Molecular Partners AG is 1.64 times less risky than XORTX Therapeutics. It trades about 0.05 of its potential returns per unit of risk. XORTX Therapeutics is currently generating about 0.02 per unit of risk. If you would invest 448.00 in Molecular Partners AG on September 2, 2024 and sell it today you would earn a total of 134.00 from holding Molecular Partners AG or generate 29.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. XORTX Therapeutics
Performance |
| Timeline |
| Molecular Partners |
| XORTX Therapeutics |
Molecular Partners and XORTX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and XORTX Therapeutics
The main advantage of trading using opposite Molecular Partners and XORTX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, XORTX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XORTX Therapeutics will offset losses from the drop in XORTX Therapeutics' long position.| Molecular Partners vs. Tff Pharmaceuticals | Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. Inhibrx | Molecular Partners vs. Enliven Therapeutics |
| XORTX Therapeutics vs. Context Therapeutics | XORTX Therapeutics vs. Neurosense Therapeutics | XORTX Therapeutics vs. Quoin Pharmaceuticals Ltd | XORTX Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets |